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A B S T R A C T
Objective: To compare the effects of pelvic ﬂoor muscle training (PFMT) performed during group
treatment sessions (GT) and individual treatment sessions (IT) to a control group (CG) of women with
stress urinary incontinence (SUI).
Hypothesis: The group treatment sessions would have better effects compared to individual treatment
sessions.
Study design: This randomized controlled pilot study included women aged over 18 years, who
complained of urinary leakage on stress and who had not undergone physical therapy for SUI before.
Forty-nine women were randomly allocated to the PFMT in group treatment session (GT) (n = 17), PFMT
in individual treatment session (IT) (n = 17) and control group (CG) (n = 15). The study was carried out in
an outpatient physical therapy department in Sa˜o Carlos, Brazil. Subjects on intervention groups were
treated with the same PFMT protocol for 6 weeks, with two 1-h weekly sessions. The GT group carried
out the PFMT in group treatment session and IT group in individual treatment session. The CG did not
receive any treatment during the corresponding time. They were evaluated before and after treatment
for primary outcome, urinary loss, and secondary outcomes, King’s Health Questionnaire, pressure
perineometry, pelvic ﬂoor muscle strength by digital palpation and subjective satisfaction. Participants,
evaluator and the physical therapist were not blinded. Forty-ﬁve women completed the study and were
included in the analysis. The statistical analysis was performed using Wilcoxon test for intragroup
analysis and Kruskal–Wallis and Mann–Whitney test for intergroup analysis (p < 0.05).
Results: In intragroup analysis, there was a signiﬁcant reduction in urinary loss measured by pad test
only in the IT group. For primary outcome, there was a signiﬁcant difference only after treatment
between GT and CG (p < 0.0001; effect size 0.91; 95% conﬁdence interval from 0.56 to 5.80) as well as
between IT and CG (p < 0.0001; effect size 0.90; 95% conﬁdence interval from 0.54 to 5.84). There were
differences after treatment in GT and IT groups for secondary outcomes: perineometry, muscle strength
and in the domains of the quality of life questionnaire. For the CG group, there were not signiﬁcant
differences in any variables. In intergroup analysis for all variables, there were no differences between GT
and IT groups. The two treated groups had similar subjective satisfaction (86%). There were no
complaints of adverse effects due to treatment from either group.
Conclusion: The results indicated similar improvement in clinical variables and in satisfaction with the
treatment between IT and GT.
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Urinary incontinence (UI) is a multifactorial syndrome deﬁned
as any involuntary loss of urine [1]. Women are 75% more affected
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Open access under the Elsevier OA license.between 25% and 45%, and even higher among elderly women.
Among the types of UI, stress urinary incontinence (SUI) is the most
prevalent [2].
There is an increasing need for UI treatment, given the
combination of ageing population and more women seeking
treatment [3], which causes a great impact on health systems
around the world. In Australia, it has been estimated that the
costs of UI treatment will total AU$ 1.27 billion in 2018 [4].
Considering the huge expense and the high incidence of UI in the
female population worldwide, it is necessary to develop
innovative strategies to overcome the challenges of this new
context. 
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for UI [5], with better results in relation to drug treatment and
surgery. It is minimally invasive, has a low rate of side effects and
low costs [6]. Among the forms of physical therapy treatment,
pelvic ﬂoor muscle training (PFMT) in individual sessions is the
most used. However, group treatment sessions could be an
appropriate therapy method with even lower costs [3]. Research
on cheap treatments for UI is especially important in countries
with low socioeconomic status, since it allows a larger number of
women to receive treatment from the public health system. Some
studies investigated the effects of group treatment compared to
home treatment and found that supervised group treatment
promotes additional beneﬁts on pelvic ﬂoor muscle strength and
increases cure rates [7,8]. Nevertheless, few studies [3,9,10]
compared the effects of PFMT performed during group sessions
and individual sessions, and there are no studies that include a
control group for comparison.
Thus, the purpose of this randomized trial was to compare the
effects of the PFMT in women with SUI performed during group
treatment sessions and individual treatment sessions to a control
group. According to literature, group treatment sessions could
present additional beneﬁts compared to the individual treatment
sessions by providing increased peer-support, mutual self-help
and, consequently, increased motivation and compliance with the
treatment [3,10]. Thus, the hypothesis of this study was that the
PFMT performed during group treatment sessions would lead to
better effects compared to individual treatment sessions.
2. Materials and methods
2.1. Subjects
This is a randomized controlled pilot study, with parallel
randomization (1:1:1), performed from August 2008 to December
2009 and conducted at the Laboratory for Assessment and
Intervention on Women’s Health, Federal University of Sa˜o Carlos.
The local ethics committee approved the study (180/2008), which
is in agreement with the Declaration of Helsinki.
This study included women aged over 18 years, who
complained of urinary leakage on stress and who had not
undergone physical therapy for UI before. Women with symptoms
of urgency urinary incontinence and mixed urinary incontinence
were excluded. Two standard questions about stress and urgency
UI were used to determine patient eligibility. For SUI the question
was ‘‘During the past month, have you involuntarily got wet while
performing some kind of physical exertion, e.g. coughing, lifting,
sneezing or laughing?’’. For the urgency UI the question was
‘‘During the past month, have you experienced such a strong urge
to urinate that it was impossible to get to the toilet in time?’’. The
sensitivity/speciﬁcity are 0.85/0.91 and 0.90/0.90 for the ﬁrst and
second questions, respectively [11]. Only women who answered
‘‘yes’’ to the ﬁrst question were recruited. Women who answered
‘‘yes’’ to the second question or to both questions were excluded.
Exclusion criteria also included latex allergies, vaginal or urinary
infections, pelvic organ prolapse greater than grade II on Baden–
Walker classiﬁcation system [12], cognitive or neurological
disorder, uncontrolled hypertension and inability to carry out
the evaluation or treatment.All participants signed an informed
consent and were instructed in regards to the study protocol. The
49 volunteers who met the inclusion criteria were randomized in
three groups: PFMT in group treatment session (GT) (n = 17), PFMT
in individual treatment session (IT) (n = 17) and control group (CG)
(n = 15). For the randomization, the participants blindly drew one
of 49 preprinted cards in opaque sealed envelopes from a box (17
labeled ‘group session’, 17 labeled ‘individual session’ and 15labeled ‘control group’) and were arranged in the groups according
to the drawn card.
2.2. Outcome measures
Only one not blinded experienced physical therapist performed
evaluations of the three groups. Initially, all women went through a
complete physical examination and an interview regarding their
thorough medical history. Women were evaluated before and after
treatment for urinary loss (primary outcome) and quality of life,
pelvic ﬂoor muscle pressure, pelvic ﬂoor muscle strength and
satisfaction with treatment (secondary outcomes). The women in
the CG carried out a similar evaluation but were not asked about
satisfaction with treatment. The primary investigator carried out a
prior evaluation of the test-retest reliability. Ten women with SUI
were tested on two occasions, separated by 1 week, to determine
the intraclass correlation coefﬁcients (ICC) and standard errors of
measurement (SEM) for all variables.
The 1-h pad test was carried out to evaluate urinary loss
according to the protocol proposed by Abrams et al. [13]. The
volunteers were instructed to wear a pad previously weighed on a
precision balance Denver APX200 (precision of 0.0001 g, Denver
Instrument, Denver, USA) and then drink 500 ml of water. After
30 min they started performing a series of provocative exercises:
walking for 10 min, including stair climbing equivalent to one
ﬂight up and down; standing up from sitting, 10 times; coughing
vigorously, 10 times; running on the spot for 1 min; bending to
pick up small object from ﬂoor, ﬁve times; and washing hands in
running water for 1 min. At the end of 1 h, the pad was removed,
reweighed and the urinary loss was calculated. The ICC and the
SEM for this variable were 0.99 and 0.45 g.
For the assessment of quality of life, the King’s Health
Questionnare (KHQ) [14] was used, as it is one reliable instrument,
speciﬁc to assess quality of life of women with UI and validated in
Portuguese/Brazil [15]. This questionnaire consists of 30 questions,
divided into nine individually scored domains. These domains
(ICC; SEM) are: general health (0.79; 8.69), incontinence impact
(0.82; 13.33), limitations of daily activities (0.97; 6.50), physical
limitations (0.93; 8.43), social limitations (0.96; 6.21), personal
relationships (0.76; 7.31), emotions (0.96; 4.05), sleep and
disposition (0.85; 11.75) and gravity (0.91; 7.60). The total score
ranges from 0 to 100 and a score of 100 represents the worst
possible quality of life, and 0 represents the best possible quality of
life [14].
To evaluate the pelvic ﬂoor muscle pressure, a Perina Stim
device (Quark Medical Products, Piracicaba, Brazil) was used,
graded from 0 to 60 cmH2O and supplied with a vaginal probe. The
volunteers were positioned in supine, with hip and knee ﬂexion.
The vaginal probe was inserted in the vagina and the device was
calibrated. Then, the volunteers were asked to perform three 3-s
maximum perceived effort contractions of pelvic ﬂoor muscles.
The volunteers were instructed not to use abdominal, gluteal and/
or hip adductor muscles during the contractions [16]. The ICC and
SEM were 0.97 and 0.53 cmH2O, respectively.
The assessment of pelvic ﬂoor muscle strength by digital
palpation was carried out using the PERFECT scheme. The
volunteers were positioned in supine with hip and knee ﬂexion.
In this position, the evaluator introduced two ﬁngers up to one
third of the vagina. The volunteer was then instructed to lift and
squeeze the pelvic ﬂoor muscle as hard as possible. The strength
measured on the 6-point Modiﬁed Oxford Scale [17]. The ICC and
SEM for this variable were 0.84 and 0.20.
In the end of treatment, the volunteers were questioned
regarding their satisfaction with treatment. The only two response
options were ‘‘satisﬁed’’ and ‘‘dissatisﬁed’’. Answering ‘‘satisﬁed’’
indicated that the patient did not want a different treatment.
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different treatment than the initial one [10].
2.3. Treatment protocol
The treatment protocol was carried out as outpatient activities
under the supervision of the same physical therapist that carried
out the evaluation. The treatment for the GT and IT groups
consisted of 12 sessions, with two 1 h sessions per week and total
of 6 weeks of treatment. Both groups were taught to contract the
pelvic ﬂoor muscles correctly, and the proper contractions were
conﬁrmed by vaginal palpation. The subjects of GT group were
divided into groups of 8–10 people for treatment.
During the sessions, volunteers received instructions about
anatomy of the pelvic ﬂoor muscles and continence mechanisms
and carried out exercises to strengthen the pelvic ﬂoor muscles in
supine, sitting and standing positions. The difﬁculty degree
progressed according to the positions adopted, increasing the
number of repetitions and time of sustained contraction. An
average of 100 contractions were performed per session, with
phasic contractions, lasting three seconds with six seconds of rest,
and tonic contractions, lasting 5–10 s followed by 10–20 s of restFig. 1. Participant [18]. To minimize the muscle fatigue, the resting time was rigidly
observed in all sessions and the time of sustained contraction was
slowly increased. At the beginning of the individual treatment, the
time of sustained contraction was the same recorded for each
woman during the initial evaluation. For the GT group, the mean
time of the group was considered as the time of sustained
contraction. For both groups, the time of sustained contraction was
increased by 1 s per week up to 10 s.
The CG did not receive any treatment during the corresponding
treatment time. After this time, subjects were evaluated and
referred to physical therapy treatment.
2.4. Statistical analysis
All statistical analyses were performed using Statistica statisti-
cal software (StatSoft Inc., Tulsa, United States). To test the normal
distribution of data in each group, the Shapiro–Wilk test was used
and to verify the homogeneity of the groups a Kruskal–Wallis test
was applied. Because the data were not normally distributed, the
intragroup analysis was carried out using Wilcoxon nonparametric
test. For the intergroup analysis the Kruskal–Wallis test was used.
Pairwise comparisons were made with the Mann–Whitney test toﬂow diagram.
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the p value was <0.05. To measure the clinical signiﬁcance of the
data, the effect size and the conﬁdence interval were calculated.
The effect sizes were considered mild if values were smaller than
0.20; moderate if values were between 0.25 and 0.75, and large
when values were over 0.80 [19].
3. Results
From the 49 women who took part in the study, two women of
GT (11.7%) and two women in the IT (11.7%) did not complete
treatment or did not perform the ﬁnal evaluation due to health
problems on family and were excluded from the sample. Forty-
nine participants were included and randomized to receive
treatment (Fig. 1), but 45 completed the study. At baseline, there
were no signiﬁcant differences between the groups in terms of
demographics and clinics characteristics (Table 1).
There was a signiﬁcant reduction in urinary loss measured by
pad test in the IT group after treatment. In CG and GT groups
there were no signiﬁcant differences in this variable, although it
has been observed a trend for the reduction in urinary loss for
the latter. In the intergroup analysis, there was a signiﬁcant
difference only after treatment between GT group and CG
(p < 0.0001; effect size 0.91; 95% conﬁdence interval from 0.56
to 5.80) as well as between IT group and CG (p < 0.0001; effect
size 0.90; 95% conﬁdence interval from 0.54 to 5.84). The
pressure perineometry of the pelvic ﬂoor muscles was signiﬁ-
cantly increased in both GT and IT groups but not for the CG. The
intergroup analysis showed statistical differences between GT
group and CG (p = 0.0001; effect size 1.78; 95% conﬁdence
interval from 14.63 to 35.81) as well as between IT group and CG
(p < 0.0001; effect size 1.87; 95% conﬁdence interval from 15.98
to 37.26) only after treatment. There was signiﬁcant improve-
ment in muscle strength as measured by the Oxford scale in GTTable 1
Baseline comparisons between the groups for demographic and clinical characteristics
GT (n = 15) IT 
Age 60.20  8.16 6
BMI 26.03  3.6 26
Pad test (g) 1.88  2.85 4
Number of deliveries 2.0  1.55 2
Vaginal delivery 1.46  1.50 1
Data presented as mean  standard deviation.
GT: group treatment; IT: individual treatment; CG: control group; and BMI: body mass ı´n
Table 2
Values of urinary loss, pressure and strength of pelvic ﬂoor muscle for the three group
Variable Groups Pre-trea
Pad test (g) GT 1.88  
IT 4.22  
CG 3.87  
Intergroup p value 0.08 
Pressure (cmH2O) GT 21.23  
IT 12.37  
CG 11.42  
Intergroup p value 0.76 
Strength GT 1.93  
IT 1.46  
CG 1.40  
Intergroup p value 0.45 
Data presented as mean  standard deviation.
GT: group treatment; IT: individual treatment; and CG: control group.
a Signiﬁcant difference (p < 0.05) according to the Wilcoxon nonparametric test.
b Signiﬁcant differences versus CG (Mann–Whitney tests).and IT groups after treatment. The intergroup analysis veriﬁed
statistical differences between GT group and CG (p < 0.0001;
effect size 2.59; 95% conﬁdence interval from 1.14 to 2.06) as
well as between IT group and CG (p = 0.0008; effect size 1.63;
95% conﬁdence interval from 0.68 to 1.84). For both variables,
there were no differences between treated groups. The CG did
not show any differences in the variables analyzed (Table 2).
In evaluation of quality of life, a signiﬁcant reduction of scores
in the incontinence impact, limitations of daily activities and
gravity domains was observed for both GT and IT groups after
treatment, as well as a signiﬁcant difference only for the GT group
in the sleep and disposition domain. In the physical limitations and
emotions domains, signiﬁcant differences after treatment were
found only in IT group. In the general health, social limitations and
personal relationships domains, no signiﬁcant differences were
observed for any of the treatment groups. In the intergroup
analysis, signiﬁcant differences were observed in incontinence
impact, physical limitations and gravity domains (p < 0.01 for all
variables) when comparing both treated groups and CG after
treatment. In the domains of limitations of daily activities and
emotions, signiﬁcant differences (p = 0.03 and p = 0.002, respec-
tively) were found only in GT group when compared to CG after
treatment. Signiﬁcant differences between GT and IT groups after
treatment were only found in personal relationships and emotions
domains (p = 0.02 and p = 0.03, respectively). For general health,
social limitations and sleep and disposition domains, there were no
differences among groups (Table 3). The effect size and 95%
conﬁdence interval for the KHQ domains were calculated and are
shown in Table 4.
Regarding satisfaction with the received treatment, 13 out of 15
volunteers (86%) from each of the treatment groups reported
positively in this matter; therefore, the two treatment groups had
the same subjective satisfaction. There were no complaints of
adverse effects due to treatment from either group..
(n = 15) CG (n = 15) p value
0.6  12.63 61.53  10.11 0.93
.26  2.79 26.0  1.84 0.99
.22  5.21 3.87  5.56 0.08
.12  1.24 2.80  1.32 0.53
.26  1.27 2.13  1.45 0.20
dex.
s before and after treatment.
tment Post-treatment Intragroup p value
2.85 0.46  0.45b 0.05
5.21 0.45  0.90b 0.0006a
5.56 3.64  4.93 0.48
<0.00001
20.19 37.13  19.24b 0.004a
9.20 38.53  19.34b 0.0003a
5.13 11.91  5.57 0.05
0.0003
1.33 3.07  0.70b 0.006a
0.63 2.73  0.96b 0.0006a
0.50 1.47  0.52 0.98
<0.00001
Table 3
Values of the domains of the King’s Health Questionnaire for the groups.
Domains Groups Pre-treatment Post-treatment p value
General health GT 31.67  17.59 30.0  14.02 0.68
IT 33.33  18.09 30.0  16.9 0.52
CG 40.0  18.41 33.33  18.92 0.14
Intergroup p value 0.14 0.90
Incontinence impact GT 53.36  27.6 28.84  30.54b 0.034a
IT 51.11  39.57 17.76  24.75b 0.005a
CG 60.0  33.80 57.84  29.47 0.98
Intergroup p value 0.70 0.0001
Limitations of daily activities GT 21.11  25.56 11.09  16.21 0.025a
IT 25.56  31.41 5.56  14.99b 0.007a
CG 30.0  37.37 29.96  36.83 0.90
Intergroup p value 0.14 0.03
Physical limitations GT 18.89  16.51 13.31  15.63b 0.097
IT 38.89  38.14 1.11  4.3b 0.005a
CG 33.36  30.88 35.56  34.42 0.98
Intergroup p value 0.10 0.01
Social limitations GT 7.38  12.31 5.97  9.08 0.75
IT 22.96  30.99 3.7  14.34 0.068
CG 16.3  29.95 17.76  29.63 0.99
Intergroup p value 0.75 0.06
Personal relationships GT 7.78  18.76 11.02  16.13c 0.68
IT 2.22  8.60 0.0  0.0 0.98
CG 4.44  11.72 4.44  11.72 1.0
Intergroup p value 0.56 0.04
Emotions GT 18.52  23.63 11.79  14.77c 0.059
IT 14.07  26.38 0.0  0.0b 0.043a
CG 24.41  28.23 24.44  28.54 1.0
Intergroup p value 0.07 0.0006
Sleep and disposition GT 21.11  23. 96 5.55  10.25 0.017a
IT 10.0  17.59 0.0  0.0 0.067
CG 12.22  28.49 12.22  28.49 1.0
Intergroup p value 0.06 0.01
Gravity GT 38.24  25.86 26.64  21.50b 0.0037a
IT 41.33  25.47 15.11  23.02b 0.0014a
CG 46.67  24.16 45.80  23.09 0.42
Intergroup p value 0.76 0.01
Data presented as mean  standard deviation.
GT: group treatment; IT: individual treatment; and CG: control group.
a Signiﬁcant difference (p < 0.05) according to the Wilcoxon nonparametric test.
b Signiﬁcant differences versus CG (Mann–Whitney tests).
c Signiﬁcant differences versus IT group (Mann–Whitney tests).
Table 4
Effect size and 95% conﬁdence interval for the King’s Health Questionnaire domains.
Outcome Effect size (95% conﬁdence interval)
GT IT
General health 0.20 (9.13 to 15.79) 0.19 (9.81 to 16.47)
Incontinence impact 0.97 (6.55–51.45) 1.47 (19.73–60.43)
Limitations of
daily activities
0.66 (2.41 to 40.15) 0.87 (3.37–45.43)
Physical limitations 0.83 (2.26–42.24) 1.40 (16.10–52.80)
Social limitations 0.54 (4.6 to 28.18) 0.60 (3.35 to 31.47)
Personal relationships 0.47 (17.13 to 3.97) 0.54 (1.76 to 10.64)
Emotions 0.56 (4.35 to 29.65) 1.21 (9.35–39.53)
Sleep and disposition 0.31 (9.34 to 22.68) 0.61 (2.85 to 27.29)
Gravity 0.86 (2.47–35.85) 1.33 (13.45–47.93)
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The effectiveness of PFMT in the treatment of SUI is well known
when compared to no treatment [16,20]. However, authors have
highlighted the need for intervention programs that can be applied
in everyday practice and in different countries, in spite of their
different health care systems [20]. The PFMT performed during
group sessions was the object of this study because it appears to bea good option for treating the huge demand of patients with SUI
with costs up to three times smaller [3]. In this study, group
treatment was as effective as individual treatment for women with
SUI. We observed improvements in amount of urine loss,
symptoms impact on quality of life, pelvic ﬂoor muscle pressure
and strength, and subjective evaluation of satisfaction for both
groups, with no statistical difference between them regarding
those variables.
Our ﬁndings do not agree with our initial expectation of better
results for the group treatment. Initial studies found that group
treatment could promote a signiﬁcant increase in the strength of
the pelvic ﬂoor muscles when compared to home treatment in
women with SUI [7] and to a control group in women after
childbirth [8]. However, those studies did not consider the
inﬂuence of group setup in the results [21]. The group setup
was prioritized given the possibility of group treatment bringing
additional beneﬁts compared to the individual treatment by
providing increased peer-support, mutual self-help and, conse-
quently, increased motivation and compliance with the treatment
[3,10].
With this hypothesis, Janssen et al. [9] compared group and
individual treatment in women with SUI, and they concluded that
both therapies reduced the severity of incontinence and the
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Camargo et al. [10] compared subjects who received group
treatment with women who underwent individual therapy and
observed decreases in urinary loss, increases in pelvic ﬂoor muscle
strength and improvement in quality of life of incontinent women
undergoing both treatments. Our results agree partially with these
studies, conﬁrming that both group and individual treatment seem
to be equally successful for treatment of SUI when compared to an
untreated control group.
In disagreement with the available literature, only the IT group
obtained signiﬁcant reduction in urinary loss measured by 1-h pad
test. But in the intergroup analysis, no differences between treated
groups were found after the treatment in this primary outcome.
Considering the importance of objective and quantitative assess-
ment of urinary loss, the 1-h pad test was introduced by the
International Continence Society (ICS), in 1983, as a way to simplify
measures of urine loss under standard conditions [22]. However,
their interpretation has been questioned since they may not reﬂect
the feeling of women about stress urinary incontinence [23]. This
may be a reason why satisfaction of the GT groups did not agree
with the measurement of urinary loss. According to Herbison et al.
[23], for the patients, quality of life is more important than
quantitative measures, such as the pad test.
The aim of treatment protocols consisting of PFMT is to improve
strength and muscle activation [24]. It is suggested that this
alteration on the pelvic ﬂoor muscles leads to permanent elevation
of the levator plate muscle to a higher resting position inside the
pelvis, ‘lifting’ the pelvic viscera and restoring normal reﬂex
activity and other protective continence mechanisms [25]. In our
study, we observed an increase in pressure and strength of the
pelvic ﬂoor muscles together with improved urinary continence, as
proposed by this theory. This result could be due to neural gains,
such as greater activation and synchronization of motor units, in
addition to increased cortical representation of trained muscles in
the primary motor cortex [26] rather than due to muscle
hypertrophy, since we proposed a 6-week treatment. However,
the decrease in urine loss cannot be attributed only to morpho-
logical changes and greater activation of the pelvic ﬂoor muscles.
The role of health information is known to be part of an effective
treatment [27]. Therefore, it is possible to consider that informa-
tion about UI also helped to improve the symptoms.
In relation to the assessment of quality of life, both treatments
were effective for the improvement of scores in the incontinence
impact, limitations of daily activities and gravity domains. This
result agrees with that of Camargo et al. [10], which also have
observed improvement in these domains for the groups that
carried out individual and group treatments. On the other hand,
these authors have also found improvement in general health,
physical and social limitations, personal relationships, emotions
and sleep and disposition domains, which disagrees with our
results. As our results, this study identiﬁed no signiﬁcant difference
between group and individual treatment in those quality of life
domains.
The IT was superior to the GT in the improvement of scores in
the physical limitations and emotions domains. As for the sleep
and disposition domain, improvement was observed only in the GT
group. Such divergent results may be due to the subjectivity of the
assessments of quality of life. It is known that suffering and the
range of difﬁculties can be related not only to age, ethnicity and
religion but also to the perception and response of each individual
about the incontinence [28].
To our knowledge there are no previous reports comparing
group treatment with an untreated control group for women with
SUI. The results of this study indicate that the treatment group
might be better than no treatment for SUI, with large treatment
effects size for urinary loss, pelvic ﬂoor muscle pressure and pelvicﬂoor muscle strength, which demonstrates the clinical signiﬁcance
of the results [19]. However, we did not evaluate the satisfaction
from the control group. Such information would enable to identify
whether, despite the absence of changes in symptoms, no training
will provide some satisfaction for the women with incontinence.
The main limitation of our study was that the therapist that
carried out the evaluation and treatment was not blinded and this
could have inﬂuenced the results, consciously or not. The small
sample size is other limitation of this study. The sample size in this
study was not large enough to detect differences between
treatment groups. Therefore, a larger sample size could have
altered some of the results of the study. However, despite the small
sample size, the calculation of effect size showed that the
treatment had a large effect on clinical variables. To reach
deﬁnitive conclusions about the individual and group treatment,
further research should carry out a non-inferiority trial to compare
both treatments.
Another limitation is the absence of urodynamic diagnosis, as it
is known that the symptomatic and urodynamic diagnoses do not
always concur [20]. However, our results showed that it is possible
that reporting of symptoms is a useful tool for the indication of
conservative treatment. The absence of a long term monitoring is
also a limitation; therefore, it was not possible to verify whether
gains were maintained through time and if any of the groups had a
better long-term outcome. Further research should include a
follow-up period. Besides, cost-effectiveness outcome tools should
be considered in the choice of tools used to evaluate the best
treatment for women with SUI.
With the ongoing search for low-cost treatments, this study
contributes to the development of efﬁcient treatment protocols
with less expense for the public health system. According
Vestergaard [29], in 1997 only 20% of women’s health physical
therapists used the group approach in the UI management. No
recent data were found on the use of group treatment by women’s
health physical therapists. The results of this study indicate similar
improvement in clinical variables and in satisfaction with the
treatment between treated groups. In addition, group work is
acknowledged within the ﬁeld of health promotion as a tool to
promote behavioral modiﬁcation through motivation, provision of
information and fostering peer support [3]. Therefore, the group
treatment should be more applied in clinical practice, especially
within public health service as it seems to be a way to carry out a
high quality treatment with lower investment.
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